- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| home:othertreatments:stimulants [08.25.2017] – [Read more] sallieq | home:othertreatments:stimulants [09.14.2022] (current) – external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 23: | Line 23: | ||
| There is no evidence that caffeine is helpful to the recovery trajectory of MP patients. Caffeine may be problematic for the following reasons: | There is no evidence that caffeine is helpful to the recovery trajectory of MP patients. Caffeine may be problematic for the following reasons: | ||
| - | * University of Iowa scientists [[http:// | + | * University of Iowa scientists [[https:// |
| - | * Caffeine can substantially contribute to bone loss.(({{pubmed> | + | * Caffeine can substantially contribute to bone loss.(({{pmid> |
| * Finally, caffeine is said to act on the cAMP and PKA pathway, and therefore it is likely to have negative effects on VDR homeostasis and on recovery. | * Finally, caffeine is said to act on the cAMP and PKA pathway, and therefore it is likely to have negative effects on VDR homeostasis and on recovery. | ||
| Line 43: | Line 43: | ||
| + | < | ||
| ===== Notes and comments ===== | ===== Notes and comments ===== | ||
| NYTimes | NYTimes | ||
| - | - Read more - | + | - Read more - |
| - | * [[http:// | + | * [[https:// |
| * Legacy content | * Legacy content | ||
| - | * http:// | + | * https:// |
| - | * http:// | + | * https:// |
| - | * http:// | + | * https:// |
| + | |||
| + | ===== References =====</ | ||
| - | ===== References ===== | ||
home/othertreatments/stimulants.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.